IDHIFA

Indicated For

Relapsed or refractory acute myeloid leukemia (AML) with IDH2 mutation

About This Medication

# BMS Access Support Patient Guide: How to Get IDHIFA at Low or No Cost ## About IDHIFA IDHIFA (enasidenib) is a prescription medicine used to treat adults with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. This medication helps patients whose disease has returned or has not improved after previous treatments. IDHIFA is manufactured by Bristol Myers Squibb (BMS) and is only available through specialty pharmacies or authorized distributors. ## Who Qualifies for Assistance Bristol Myers Squibb offers multiple assistance programs through **BMS Access Support** to help eligible patients access IDHIFA: ### Co-Pay Assistance Program This program is available to **eligible, commercially insured patients** who have been prescribed IDHIFA. It helps reduce out-of-pocket co-payment or co-insurance costs. Patients with government insurance (Medicare, Medicaid, TRICARE) are not eligible for this co-pay program but may qualify for other support options. ### Patient Assistance Program (Free Medication) For patients who are uninsured or underinsured and struggling financially, BMS may provide IDHIFA free of charge if you meet specific income and eligibility requirements. This program is designed for those without insurance coverage for their BMS medications. ## Income Eligibility While specific income thresholds are not publicly detailed in standard materials, the patient assistance program generally considers: - Your household income level - Family size - Financial hardship circumstances - Current insurance status For the most accurate income eligibility information specific to your situation, contact BMS Access Support directly at **1-800-861-0048**. A Patient Access Specialist can review your individual circumstances and determine your eligibility. ## Insurance Requirements **Commercially Insured Patients:** You are eligible for the co-pay assistance program if you have active commercial insurance coverage. **Medicare Patients:** You are not eligible for BMS co-pay assistance programs. However, you may qualify for: - Medicare Extra Help/Low-Income Subsidy (LIS) program, which reduces out-of-pocket costs - Medicare Prescription Payment Plan, which allows you to spread medication costs over time - State Pharmaceutical Assistance Programs - Independent charitable foundations (BMS Access Support can provide information about these) **Medicaid and TRICARE Patients:** Similar to Medicare, you are not eligible for BMS co-pay programs but may access other support resources through BMS Access Support. **Uninsured Patients:** You may qualify for the patient assistance program offering free or low-cost medication. ## How to Apply ### Step 1: Gather Your Information Before contacting BMS Access Support, have the following ready: - Your prescription for IDHIFA - Insurance information (if applicable) - Proof of income or financial documents (for patient assistance program) - Identification ### Step 2: Contact BMS Access Support Reach out to BMS Access Support to begin the enrollment process: - **Phone:** 1-800-861-0048 - **Website:** Visit BMS Access Support online for additional resources - A Patient Access Specialist will guide you through the application ### Step 3: Complete Your Application Provide the required information and documentation. The application process is designed to be straightforward and easy to initiate. ### Step 4: Benefits Review Once enrolled, BMS Access Support will: - Review your insurance coverage - Determine if IDHIFA is covered by your plan - Identify if prior authorization is required - Provide an estimate of your out-of-pocket costs - This review typically takes approximately **24 hours** ### Step 5: Receive Your Support Depending on your program: - **Co-pay assistance:** Receive co-pay card or assistance with out-of-pocket costs - **Patient assistance:** Receive medication at no cost if approved ## Timeline and Delivery **Benefits Review:** Approximately 24 hours after enrollment **Medication Delivery:** IDHIFA is distributed through specialty pharmacies or authorized distributors. Once your assistance is approved, your healthcare provider will work with the specialty pharmacy to dispense your medication. Delivery timelines depend on your specific pharmacy and location. **Ongoing Support:** BMS Access Support provides continued assistance throughout your treatment, including prior authorization support and appeals process assistance if needed. ## What If Your Application Is Denied If your application for assistance is denied: 1. **Request clarification** from BMS Access Support about the reason for denial 2. **Appeal the decision** - BMS Access Support offers appeal process support 3. **Explore alternatives:** - If you have government insurance, ask about independent charitable foundations that may provide support - Contact patient advocacy organizations like the Aplastic Anemia and MDS International Foundation or American Society of Clinical Oncology for additional resources - Investigate state-funded pharmaceutical assistance programs - Ask your healthcare provider about clinical trials or other treatment options ## Reauthorization Your assistance may require annual reverification. BMS Access Support will notify you when reauthorization is needed and guide you through the renewal process. Keep your contact information current with BMS Access Support to ensure you receive timely notifications. ## Additional Resources Beyond financial assistance, BMS Access Support provides: - Prior authorization assistance - Appeals process support - Benefit investigation and coverage information - Patient support in multiple languages - Information about transportation and other support services For comprehensive support, contact BMS Access Support or visit their website for additional resources and tools. ## Important Disclaimer This guide provides general information about BMS Access Support programs for IDHIFA. Eligibility criteria, program details, and requirements may change. Bristol Myers Squibb takes no responsibility for the content of external resources. For the most current and accurate information about your specific situation, contact BMS Access Support directly at 1-800-861-0048 or consult with your healthcare provider. This information is intended for U.S. residents 18 years or older.

Program information last verified: March 30, 2026